JSC
ARNA

Jackson Square Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Jackson Square Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-298
Closed -$22K – 351
2020
Q3 		$22K Buy
+298
New +$19.9K 0.01% 216

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jackson Square Capital's ARNA Position: Q4 2020 in Review

Jackson Square Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 298 shares — an estimated $22K sold.

Jackson Square Capital first reported a position in ARNA in Q3 2020 and held it in 1 quarter. The position peaked at $22K in Q3 2020. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Jackson Square Capital reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Jackson Square Capital sold 298 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $22K.
  • Jackson Square Capital first reported a position in Arena Pharmaceuticals Inc in Q3 2020 and held it in 1 quarter.
  • Jackson Square Capital's Arena Pharmaceuticals Inc position peaked at $22K in Q3 2020.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Jackson Square Capital's 13F filing for Q4 2020, filed 5 Mar 2021.